GerosMicro
Financial Marketplace
Investment & Growth Platform
Preparing your investment experience
Initializing platform... 00%
Vir Biotechnology reports positive hepatitis results, early signs of possible cure (VIR:NASDAQ)
  • seekingalpha.com
  • Posted On 08 November 2026

Vir Biotechnology reports positive hepatitis results, early signs of possible cure (VIR:NASDAQ)

Vir plans to seek FDA approval in mid-2027 and expects additional Eclipse 2 and Eclipse 3 results in the first quarter of 2027. Breakthrough therapy and fast tr...
Source: seekingalpha.com
Share Now

Live Support

We're here to help

CUSTOMER SUPPORT

Hello! How can we help you?

Send us a message and our Protocol Officer will assist you.

Connecting to support...